Skip to main content

Closed

LITS: Lite Strategy, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-22.4%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio11.53×

Lite Strategy, Inc.

LITSNASDAQ Capital Market·USD·Closed

Lite Strategy, Inc.

LITSNASDAQ·USD·Closed

$0.96

−2.40%

$0.96

−$0.02 (2.40%)

52W Range

6thpctl

Volume

0.16×avg

Mkt Cap

32.78MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

6thpctl

Volume

0.16×avg

Market Cap

32.78MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings